---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024632"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:49:13.476143+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma raises $41K via convertible note with 35% discount conversion

## Summary
- Issued $49,200 convertible promissory note to 1800 Diagonal Lending LLC for $41,000, net proceeds for working capital.
- Note bears 15% one-time interest, maturity April 15, 2025, with five scheduled payments totaling $56,580.
- Conversion price set at 65% of lowest trading price over 10 prior trading days (35% discount) upon event of default.
- Investor is accredited; note issued under Section 4(a)(2) and Regulation D exemption.

## SEC filing metadata
- accession: 0001493152-24-024632
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315224024632/0001493152-24-024632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315224024632/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024632
- JSON: https://secwatch.observer/filing/0001493152-24-024632.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024632.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.